Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2089-2095

  Factor, Valentina M ^a   Kao, Chien Yuan ^a   Santoni Rugiu, Eric ^a   Woitach, Joseph T ^a   Jensen, Michael R ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; TRANSFORMING GROWTH FACTOR BETA1;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE TARGETING; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, NORTHERN; DIETHYLNITROSAMINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0030912962     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kingsley, D. M. The TGF-β superfamily: new genetic tests of function in different organisms. Genes & Dev., 8: 133-146, 1994.
2. Roberts, A. B., Thompson, N. L., Heine, U., Flanders, K. C., and Sporn, M. B. Transforming growth factor β: possible roles in carcinogenesis. Br. J. Cancer, 57: 594-600, 1988.
3. Fynn, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor βand its role in oncogenesis. Crit. Rev. Oncog., 4: 493-540, 1993.
4. Schulte-Hermann, R., Grasl-Kraupp, B., and Bursch, W. Apoptosis and hepatocarcinogenesis. In: R. L. Jirtle (ed.), Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms, pp. 141-177. San Diego, CA: Academic Press, 1995.
5. Fausto, N., Mead, J. E., Gruppuso, P. A., and Braun, L. TGF-β in liver development, regeneration, and carcinogenesis. Ann. NY Acad. Sci., 593: 231-242, 1990.
6. Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, R., Wind, L., Biempica, L., and Zern, M. A. In vitro and in vivo association of transforming growth factor β1 with hepatic fibrosis. J. Cell Biol., 108: 2477-2482, 1989.
7. Bedossa, P., Peltier, E., Terris, B., Franco, D., and Poynard, T. Transforming growth factor β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology, 21: 760-766, 1995.
8. Massagué, J. TGF-β signaling: receptors, transducers, and Mad proteins. Cell, 85: 947-950, 1996.
9. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balman, A., and Akhurst, R. J. TGF-β1 inhibits the formation of benign skin tumors but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86: 531-542, 1996.
10. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., and Reichmann, E. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes & Dev., 10: 2462-2477, 1996.
11. Pierce, D. F., Jr., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffrey, R. J., Jr., and Moses, H. L. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA, 92: 4254-4258, 1995.
12. Garte, S. J. The c-myc oncogene in tumor progression. Crit. Rev. Oncog., 4: 435-449, 1993.
13. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
14. Alexandrow, M. G., Kawabata, M., Aakre, M., and Moses, H. L. Overexpression of c-myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β. Proc. Natl. Acad. Sci. USA, 92: 3239-3243, 1995.
15. Houck, K. A., Michalopoulos, G. K., and Strom, S. C. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth-inhibitory effects of TGF-β. Oncogene, 4: 19-25, 1989.
16. Strom, S. C., and Faust, J. B. Oncogene activation and hepatocarcinogenesis. Pathobiology, 58: 153-167, 1990.
17. Sanderson, N., Factor, V. M., Nagy, P., Kopp, J., Konaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., and Thorgeirsson, S. S. Hepatic expression of mature transforming growth factor β in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA, 92: 2572-2576, 1995.
18. Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Böttinger, E. P., Klotman, P. E., and Thorgeirsson, S. S. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab. Invest., 74: 991-1003, 1996.
19. Murakami, H., Sanderson, N., Nagy, P., Marino, P., Merlino, G. T., and Thorgeirsson, S. S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and TGF-α in hepatic oncogenesis. Cancer Res., 53: 1719-1723, 1993.
20. Santoni-Rugiu, E., Nagy, P., Jensen, M. R., Factor, V. M., and Thorgeirsson, S. S. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myr and transforming growth factor α. Am. J. Pathol., 149: 407-428, 1996.
21. Santoni-Rugiu, E., Preisegger, K. H., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E. V., and Thorgeirsson, S. S. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc. Natl. Acad. Sci. USA, 93: 9577-9582, 1996.
22. Frith, C. H., Ward, J. M., and Turusov, V. S. Tumours of the liver. In: V. S. Turusov and U. Mohr (eds.), Pathology of Tumours in Laboratory Animals, Vol. 2, pp. 223-270. Lyon, France: IARC Scientific Publications, 1994.
23. Engelhardt, N. V., Factor, V. M., Medvinsky, A. L., Baranov, V. N., Lazareva, M. N., and Poltoranina, V. S. Common antigen of oval and biliary epithelial cells (A6) is a differentiation marker of epithelial and erythroid cell lineages in early development of the mouse. Differentiation, 55: 19-26, 1993.
24. Koen, H., Pugh, T. D., Nychka, D., and Goldfarb, S. Presence of a-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice. Cancer Res., 43: 702-708, 1983.
25. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Lang, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. Loss of expression of transforming growth factor α type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res., 2: 1255-1261, 1996.
26. Freeman, J. W., Mattingly, C. A., and Strodel, W. E. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-β1 type RII receptor. J. Cell. Physiol., 165: 155-163, 1995.
27. Kalkhoven, E., Roelen, B. A. J., de Winter, J. P., Mummery, C. L., van den Eijnden-van, R., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth & Differ., 6: 1151-1161, 1995.
28. Mansbach, J., Mills, J. J., Boyer, I. J., DeSouza, A. T., Hankins, G. R., and Jirtle, R. L. Phenobarbital selectively promotes initiated cells with reduced TGF-β receptor levels. Carcinogenesis (Lond.), 17: 171-174, 1996.
29. Zhang, X., Wang, T., Batist, G., and Tsao, M-S. Transforming growth factor β1 promotes spontaneous transformation of cultured rat liver epithelial cells. Cancer Res., 54: 6122-6128, 1994.
30. Huggett, A. C., Ellis, P. A., Ford, C. P., Hampton, L. L., Rimoldi, D., and Thorgeirsson, S. S. Development of resistance to the growth-inhibitory effects of transforming growth factor β1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res., 57: 5929-5936, 1991.
31. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zbrowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
32. Garriegue-Antar, L., Souza, R. F., Vellucci, V. F., Meltzer, S. J., and Reiss, M. Loss of transforming growth factor β type II receptor gene expression in primary human esophageal cancer. Lab. Invest., 75: 263-272, 1996.
33. Grisham, J. W., and Thorgeirsson, S. S. Liver stem cells. In: C. S. Potten (ed.), Stem Cells, pp. 233-282. New York: Academic Press, 1997.
34. Hecht, F., Hecht, B., Chatel, M., Gaudray, P., and Turc-Carel, C. Nonrandom sex chromosome changes in brain tumors. Cancer Genet. Cytogenet., 72: 160, 1994.